Adoptive immunotherapy for cancer: harnessing the T cell response | Nature Reviews Immunology
Frontiers | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome | Pharmacology
Genetic Screening for Novel Regulators of Immune Checkpoint Molecules: Trends in Immunology
Immuno-Oncology: New breakthrough of cancer treatment - ppt download
Cancer Hallmarks adlı kullanıcının cancer immunology panosundaki Pin
The Promise of Immunotherapy for Cancer Treatment - ppt video online download
Regulation of PD-L1: a novel role of pro-survival signalling in cancer - Annals of Oncology
Frontiers | The Future of Immunotherapy: A 20-Year Perspective | Immunology
Organoid Models of Tumor Immunology: Trends in Immunology
New kids on the block:
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer
Monitoring the Balance Between Immune Repression and Stimulation in Cancer Immunotherapy - Drug Discovery World (DDW)
IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology | HTML
Frontiers | PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells | Immunology
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer
Adoptive immunotherapy for cancer: harnessing the T cell response | Nature Reviews Immunology
Pardoll DM. Spinning molecular immulogy into successful immunotherapy. Nat Rev Immunol2: 227-238 | Request PDF
Immune Checkpoints: Regulators of the immune system - Bethyl Laboratories
Immune checkpoint - Wikipedia
Immune modulation for cancer therapy | British Journal of Cancer
Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies | Immunology
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer
Hallmarks of response to immune checkpoint blockade | British Journal of Cancer
